Publication Information

{'id': 'https://openalex.org/W2043940598', 'doi': 'https://doi.org/10.1016/0006-2952(95)98499-y', 'title': 'Kinetic characteristics of zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase', 'display_name': 'Kinetic characteristics of zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase', 'publication_year': 1995, 'publication_date': '1995-04-01', 'ids': {'openalex': 'https://openalex.org/W2043940598', 'doi': 'https://doi.org/10.1016/0006-2952(95)98499-y', 'mag': '2043940598', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/7748183'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0006-2952(95)98499-y', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S185534594', 'display_name': 'Biochemical Pharmacology', 'issn_l': '0006-2952', 'issn': ['0006-2952', '1873-2968'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5040954897', 'display_name': 'Peter N. Cook', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Peter N. Cook', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018041562', 'display_name': 'Walter H.J. Ward', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Walter H.J. Ward', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004778896', 'display_name': 'J. Mark Petrash', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J.Mark Petrash', 'raw_affiliation_strings': ['Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8096, St Louis, MO 63110, U.S.A.'], 'affiliations': [{'raw_affiliation_string': 'Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8096, St Louis, MO 63110, U.S.A.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042099644', 'display_name': 'Donald J. Mirrlees', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Donald J. Mirrlees', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036460681', 'display_name': 'Christopher M. Sennitt', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Christopher M. Sennitt', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074299625', 'display_name': 'Frank Carey', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Frank Carey', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064823867', 'display_name': 'John R. Preston', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John Preston', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046616738', 'display_name': 'David R. Brittain', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'David R. Brittain', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087581579', 'display_name': 'D.P. Tuffin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'David P. Tuffin', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5018450151', 'display_name': 'Ralph Howe', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ralph Howe', 'raw_affiliation_strings': ['ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.'], 'affiliations': [{'raw_affiliation_string': 'ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3700, 'currency': 'USD', 'value_usd': 3700, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.167, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.525027, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 81, 'max': 82}, 'biblio': {'volume': '49', 'issue': '8', 'first_page': '1043', 'last_page': '1049'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12533', 'display_name': 'Cellular Response to Osmotic Stress and Metabolism', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12533', 'display_name': 'Cellular Response to Osmotic Stress and Metabolism', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11633', 'display_name': 'Effects of Prenatal Alcohol Exposure on Offspring', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10414', 'display_name': 'Endocannabinoid System and Its Effects on Health', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/aldehyde-reductase', 'display_name': 'Aldehyde Reductase', 'score': 0.8674262}, {'id': 'https://openalex.org/keywords/uncompetitive-inhibitor', 'display_name': 'Uncompetitive inhibitor', 'score': 0.6733819}, {'id': 'https://openalex.org/keywords/aldose-reductase', 'display_name': 'Aldose Reductase', 'score': 0.544542}, {'id': 'https://openalex.org/keywords/aldo-keto-reductase-superfamily', 'display_name': 'Aldo-Keto Reductase Superfamily', 'score': 0.517182}], 'concepts': [{'id': 'https://openalex.org/C2776439734', 'wikidata': 'https://www.wikidata.org/wiki/Q414213', 'display_name': 'Aldose reductase', 'level': 3, 'score': 0.98763824}, {'id': 'https://openalex.org/C2778592357', 'wikidata': 'https://www.wikidata.org/wiki/Q903881', 'display_name': 'Methylglyoxal', 'level': 3, 'score': 0.8908082}, {'id': 'https://openalex.org/C2910800646', 'wikidata': 'https://www.wikidata.org/wiki/Q414213', 'display_name': 'Aldehyde Reductase', 'level': 4, 'score': 0.8674262}, {'id': 'https://openalex.org/C2776779347', 'wikidata': 'https://www.wikidata.org/wiki/Q245280', 'display_name': 'Sorbitol', 'level': 2, 'score': 0.8124714}, {'id': 'https://openalex.org/C2777374081', 'wikidata': 'https://www.wikidata.org/wiki/Q4713968', 'display_name': 'Aldose reductase inhibitor', 'level': 4, 'score': 0.7410301}, {'id': 'https://openalex.org/C14728290', 'wikidata': 'https://www.wikidata.org/wiki/Q7882889', 'display_name': 'Uncompetitive inhibitor', 'level': 4, 'score': 0.6733819}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.64633703}, {'id': 'https://openalex.org/C2776851017', 'wikidata': 'https://www.wikidata.org/wiki/Q409079', 'display_name': 'Aldose', 'level': 3, 'score': 0.57019556}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.5104939}, {'id': 'https://openalex.org/C134651460', 'wikidata': 'https://www.wikidata.org/wiki/Q3100717', 'display_name': 'Reductase', 'level': 3, 'score': 0.45700726}, {'id': 'https://openalex.org/C150757390', 'wikidata': 'https://www.wikidata.org/wiki/Q1985205', 'display_name': 'Non-competitive inhibition', 'level': 3, 'score': 0.4302168}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.38233015}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.3579576}, {'id': 'https://openalex.org/C194671627', 'wikidata': 'https://www.wikidata.org/wiki/Q192639', 'display_name': 'Glycoside', 'level': 2, 'score': 0.06516683}], 'mesh': [{'descriptor_ui': 'D000083', 'descriptor_name': 'Acetanilides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000449', 'descriptor_name': 'Aldehyde Reductase', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D007908', 'descriptor_name': 'Lens, Crystalline', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': True}, {'descriptor_ui': 'D013450', 'descriptor_name': 'Sulfones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000083', 'descriptor_name': 'Acetanilides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000449', 'descriptor_name': 'Aldehyde Reductase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002417', 'descriptor_name': 'Cattle', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005947', 'descriptor_name': 'Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005947', 'descriptor_name': 'Glucose', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007668', 'descriptor_name': 'Kidney', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007668', 'descriptor_name': 'Kidney', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D007700', 'descriptor_name': 'Kinetics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007908', 'descriptor_name': 'Lens, Crystalline', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009249', 'descriptor_name': 'NADP', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011765', 'descriptor_name': 'Pyruvaldehyde', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D011765', 'descriptor_name': 'Pyruvaldehyde', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013450', 'descriptor_name': 'Sulfones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0006-2952(95)98499-y', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S185534594', 'display_name': 'Biochemical Pharmacology', 'issn_l': '0006-2952', 'issn': ['0006-2952', '1873-2968'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/7748183', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.45, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 29, 'referenced_works': ['https://openalex.org/W109739307', 'https://openalex.org/W137296389', 'https://openalex.org/W1462994058', 'https://openalex.org/W1487399358', 'https://openalex.org/W149964163', 'https://openalex.org/W1558758492', 'https://openalex.org/W1581592573', 'https://openalex.org/W1604507293', 'https://openalex.org/W1605340054', 'https://openalex.org/W1673924402', 'https://openalex.org/W183948027', 'https://openalex.org/W1889077695', 'https://openalex.org/W1964722373', 'https://openalex.org/W1966145329', 'https://openalex.org/W1972857511', 'https://openalex.org/W1981410337', 'https://openalex.org/W1991065242', 'https://openalex.org/W2000237824', 'https://openalex.org/W2009185801', 'https://openalex.org/W2011612881', 'https://openalex.org/W2013901674', 'https://openalex.org/W2019940358', 'https://openalex.org/W2030801541', 'https://openalex.org/W2057523983', 'https://openalex.org/W2072233021', 'https://openalex.org/W2086719889', 'https://openalex.org/W2093012663', 'https://openalex.org/W2287384351', 'https://openalex.org/W78503369'], 'related_works': ['https://openalex.org/W4308808838', 'https://openalex.org/W2181456896', 'https://openalex.org/W2147292673', 'https://openalex.org/W2080608495', 'https://openalex.org/W2043940598', 'https://openalex.org/W2028656516', 'https://openalex.org/W1989926008', 'https://openalex.org/W1973787054', 'https://openalex.org/W1972371821', 'https://openalex.org/W1966962173'], 'abstract_inverted_index': {'Aldose': [0], 'reductase': [1, 3, 19, 42, 72, 114, 149, 205, 247, 272, 274, 287, 310], '(aldehyde': [2, 273], '2)': [4], 'catalyses': [5], 'the': [6, 28, 192, 196, 228, 235, 267], 'conversion': [7], 'of': [8, 30, 40, 55, 84, 145, 195, 198, 208, 233, 283], 'glucose': [9, 117, 151, 178], 'to': [10, 14, 26, 166, 216, 256, 279, 295, 312], 'sorbitol,': [11], 'and': [12, 75, 98, 127, 179, 238, 259], 'methylglyoxal': [13, 119], 'acetol.': [15], 'Treatment': [16], 'with': [17, 133, 164, 177, 188, 214, 231, 254, 293], 'aldose': [18, 41, 71, 113, 148, 157, 204, 225, 246, 280, 309], 'inhibitors': [20, 229, 248], '(ARIs)': [21], 'is': [22, 62, 120, 137, 152, 191, 276], 'a': [23, 36, 56, 79, 199, 217, 302], 'potential': [24], 'approach': [25], 'decrease': [27], 'development': [29], 'diabetic': [31], 'complications.': [32], 'The': [33], 'sulphonylnitromethanes': [34], 'are': [35, 212], 'recently': [37], 'discovered': [38], 'class': [39], 'inhibitors,': [43], 'first': [44, 193], 'exemplified': [45], 'by': [46, 288], 'ICI': [47, 103, 134], '215918.': [48], 'We': [49], 'now': [50], 'describe': [51], 'enzyme': [52], 'kinetic': [53], 'characterization': [54], 'second': [57], 'sulphonylnitromethane,': [58], '3′,5′-dimethyl-4′-nitromethylsulphonyl-2-(2-tolyl)acetanilide': [59], '(ZD5522),': [60], 'which': [61, 76, 136], 'at': [63], 'least': [64], '10-fold': [65], 'more': [66], 'potent': [67], 'against': [68, 110], 'bovine': [69, 111, 146, 284, 308], 'lens': [70, 112, 147], 'in': [73, 89], 'vitro': [74], 'also': [77], 'has': [78], 'greater': [80, 304], 'efficacy': [81], 'for': [82, 96, 102, 224, 307], 'reduction': [83], 'rat': [85], 'nerve': [86], 'sorbitol': [87], 'levels': [88], 'vivo': [90], '(ED95': [91], '=': [92, 123, 125, 142, 170, 174, 181, 185, 298], '2.8': [93], 'mg': [94, 100], 'kg−1': [95, 101], 'ZD5522': [97, 105, 159, 289], '20': [99], '215918).': [104], 'follows': [106, 290], 'pure': [107], 'noncompetitive': [108, 162, 250], 'kinetics': [109, 163, 253, 292], 'when': [115, 150], 'either': [116, 202], 'or': [118, 206, 251], 'varied': [121], '(Kis': [122, 169], 'Kii': [124, 184], '7.2': [126], '4.3': [128], 'nM,': [129, 172, 183], 'respectively).': [130], 'This': [131, 190, 241], 'contrasts': [132], '215918': [135], 'an': [138, 264], 'uncompetitive': [139, 252, 291], 'inhibitor': [140], '(Kii': [141, 297], '100': [143], 'nM)': [144], 'varied.': [153], 'Against': [154], 'human': [155, 203], 'recombinant': [156], 'reductase,': [158, 226], 'displays': [160], 'mixed': [161], 'respect': [165, 255, 294], 'both': [167, 234], 'substrates': [168], '41': [171], 'kii': [173], '8': [175], 'nM': [176, 187], 'Kis': [180], '52': [182], '3.8': [186], 'methylglyoxal).': [189], 'report': [194], 'effects': [197], 'sulphonylnitromethane': [200], 'on': [201], 'utilization': [207], 'methylglyoxal.': [209], 'These': [210], 'results': [211], 'discussed': [213], 'reference': [215], 'Di': [218], 'Iso': [219], 'Ordered': [220], 'Bi': [221, 222], 'mechanism': [223], 'where': [227], 'compete': [230], 'binding': [232, 269], 'aldehyde': [236, 257, 286, 313], 'substrate': [237, 268], 'alcohol': [239], 'product.': [240], 'model': [242], 'may': [243], 'explain': [244], 'why': [245], 'follow': [249], 'substrates,': [258], 'X-ray': [260], 'crystallography': [261], 'paradoxically': [262], 'locates': [263], 'ARI': [265], 'within': [266], 'site.': [270], 'Aldehyde': [271], '1)': [275], 'closely': [277], 'related': [278], 'reductase.': [281, 314], 'Inhibition': [282], 'kidney': [285], 'glucuronate': [296], '39': [299], 'nM),': [300], 'indicating': [301], 'selectivity': [303], 'than': [305], '5-fold': [306], 'relative': [311]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2043940598', 'counts_by_year': [{'year': 2015, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-25T16:35:53.526779', 'created_date': '2016-06-24'}